EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Intra-articular Methotrexate-Loaded Microsponge as an Adjuvant Strategy for Rheumatoid Arthritis: Localized Treatment with a Systemic Impact

Patrizia Nadia Hanieh iD, Noemi Fiaschini, Anna Scotto d'Abusco iD, Alessia Mariano iD, Valeria Palumbo, Manuel Scimeca, Mariano Venanzi iD, Francesca Cavalieri, Carlo Abbate, Maurizio Mattei, Luigi Gentile iD, Antonio Rinaldi und 2 weitere

ACS Biomaterials Science & Engineering · 09.03.2026 · 12 (3) · 1603-1615

DOI: 10.1021/acsbiomaterials.5c01884 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Biomaterials Science & Engineering, online erschienen am 24.02.2026. Verfasst von Patrizia Nadia Hanieh und 13 weiteren Autor:innen. Beteiligte Einrichtung: Nanofaber S.r.l., Via Anguillarese 301, 00123 Rome, Italy. Hauptthemen laut MEDLINE: Methotrexate, Arthritis, Rheumatoid, Antirheumatic Agents, Drug Carriers. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Lazio Innova, H2020 Marie Sklodowska-Curie Actions, Ministero dell'Universit? e della Ricerca.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

High Resolution Image Download MS PowerPoint Slide Rheumatoid arthritis (RA) is a debilitating autoimmune disease characterized by chronic synovial inflammation and progressive joint destruction. Methotrexate (MTX) remains the gold standard in RA therapy, yet systemic administration often provides suboptimal joint targeting and causes dose-limiting toxicity. This study investigates intra-articular (IA) administration of an MTX-loaded Microsponge (MTX-MSP) as a localized strategy to enhance drug retention while minimizing systemic exposure. MTX-MSP is synthesized using hyaluronic acid-based cross-linking and MTX loading. Drug release and carrier mass loss were evaluated in a pathological human synovial fluid (HSF), and rheological and Fourier transform infrared spectroscopy analyses assess viscoelastic behavior and drug–carrier interactions. Biocompatibility and anti-inflammatory activity are tested in primary RA fibroblast-like synoviocytes, while therapeutic efficacy is evaluated in a collagen-induced arthritis rat model. MTX-MSP provides sustained release in HSF for 14 days, minimizes burst effects, and preserves structural integrity. Rheological profiling confirms injectability and interaction with the pathological synovial fluid, enhancing the elastic response. In vitro, MTX-MSP reduces IL-6, TNF-α, and IL-1β expression at gene and protein levels, outperforming free MTX. In vivo, weekly IA injections improve histological scores in treated and contralateral joints, suggesting systemic immunomodulation. MTX-MSP thus achieves prolonged release, anti-inflammatory efficacy, and reduced systemic toxicity, representing a promising IA formulation for RA management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethotrexateArthritis, RheumatoidAntirheumatic AgentsDrug CarriersAnimalsHumansRatsInjections, Intra-ArticularSynovial FluidHyaluronic AcidArthritis, ExperimentalMale

Stichwörter der Autor:innen

advanced therapiesintra-articular deliverymicrospongespathological synovial fluidrheumatoid arthritissustained release

Substanzen

MethotrexateAntirheumatic AgentsDrug CarriersHyaluronic Acid

Autor:innen und Institutionen

  • Nanofaber S.r.l., Via Anguillarese 301, 00123 Rome, Italy.
  • Department of Biochemical Sciences Alessandro Rossi Fanelli, Sapienza University of Rome, Piazzale Aldo Moro 5, 00185 Rome, Italy.
  • Department of Experimental Medicine, University of Rome Tor Vergata, Via Montpellier 1, Rome 00133, Italy.
  • Department of Chemical Science and Technologies, University of Rome Tor Vergata, Via della Ricerca Scientifica 1, 00133 Rome, Italy.
  • Interdepartmental Center for Comparative Medicine, Alternative Techniques and Aquaculture (CIMETA), University of Rome Tor Vergata, Via Montpellier 1, Rome 00133, Italy.
  • Department of Chemistry, University of Bari and CSGI (Center for Colloid and Surface Science), via Orabona 4, 70125 Bari, Italy.

ORCID-Profile: Patrizia Nadia Hanieh, Anna Scotto d'Abusco, Alessia Mariano, Mariano Venanzi, Luigi Gentile, Roberta Bernardini

Förderung

  • Lazio Innova
  • H2020 Marie Sklodowska-Curie Actions
  • Ministero dell'Universit? e della Ricerca

Zitieren

APA

Hanieh, P. N., Fiaschini, N., Scotto d'Abusco, A., Mariano, A., Palumbo, V., Scimeca, M., Venanzi, M., Cavalieri, F., Abbate, C., Mattei, M., Gentile, L., Rinaldi, A., Bernardini, R., & Migliore, A. (2026). Intra-articular Methotrexate-Loaded Microsponge as an Adjuvant Strategy for Rheumatoid Arthritis: Localized Treatment with a Systemic Impact. ACS Biomaterials Science & Engineering, 12(3), 1603-1615. https://doi.org/10.1021/acsbiomaterials.5c01884

Vancouver

Hanieh PN, Fiaschini N, Scotto d'Abusco A, Mariano A, Palumbo V, Scimeca M, et al. Intra-articular Methotrexate-Loaded Microsponge as an Adjuvant Strategy for Rheumatoid Arthritis: Localized Treatment with a Systemic Impact. ACS Biomaterials Science & Engineering. 2026;12(3):1603-1615. doi:10.1021/acsbiomaterials.5c01884

BibTeX
@article{Hanieh2026,
  author = {Hanieh, Patrizia Nadia and Fiaschini, Noemi and Scotto d'Abusco, Anna and Mariano, Alessia and Palumbo, Valeria and Scimeca, Manuel and Venanzi, Mariano and Cavalieri, Francesca and Abbate, Carlo and Mattei, Maurizio and Gentile, Luigi and Rinaldi, Antonio and Bernardini, Roberta and Migliore, Alberto},
  title = {Intra-articular Methotrexate-Loaded Microsponge as an Adjuvant Strategy for Rheumatoid Arthritis: Localized Treatment with a Systemic Impact},
  journal = {ACS Biomaterials Science & Engineering},
  year = {2026},
  volume = {12},
  number = {3},
  pages = {1603--1615},
  doi = {10.1021/acsbiomaterials.5c01884}
}
Kostenlos starten →